News Highlights: Top Company News of the Day
Disney Isn't Investigating Handling of Misconduct Claims, After ABC News Boss Urged Inquiry
ABC News President Kim Godwin had called for an external probe
of the matter last month, but a top staffer said Disney executive
Peter Rice won't pursue one.
Former Oppenheimer Analyst Charged With Insider Trading
Sergei Polevikov is accused of using his wife's personal
brokerage account to buy or sell stock in advance of large pending
purchases or sales by his employer, OppenheimerFunds, and allegedly
netting $8.5 million in profit.
Darden Says Sales on Track to Outperform Pre-Pandemic Levels
The Olive Garden parent sees inflation of about 4% as commodity
and labor costs rise.
Salesforce Boosts Sales Outlook
The business software provider has benefited from companies'
growing reliance on cloud-based tools during the pandemic, with the
spread of the Delta variant of Covid-19 prolonging that trend.
Dell Plans Buybacks, Provides Post-Spinoff Outlook
The company estimated revenue will increase at an annual rate of
3% to 4% through the fiscal year ending in January 2026.
British Airways Scraps Plan for New Short-Haul Venture
The airline abandoned a plan to create a new short-haul
subsidiary after failing to win support from its pilots for the
venture, which it had hoped would offer a way to offset
pandemic-induced declines in long-haul traffic.
TPG Appoints New President, Makes Other Management Changes
The private-equity firm is moving a group of longtime partners
into leadership roles as it prepares to launch an initial public
offering of its shares.
New Platform Backed by Fidelity, Goldman Seeks to Bring IPO Market Into Digital World
Capital Markets Gateway looks to transform a business long
accustomed to phone calls and pieces of paper.
Microsoft Keeps Surface in Its Place
Microsoft's new devices come as a reporting change makes clear
that hardware is but a small piece of the software giant's growing
Big Pharma Isn't Done Rolling Out Covid Treatments
Oral antiviral treatments for Covid-19 could give a public
health boost and generate blockbuster sales for the drug
(END) Dow Jones Newswires
September 23, 2021 15:15 ET (19:15 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.